Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata

This publication has 11 references indexed in Scilit:

• Histopathologic Findings in 107 Uterine Leiomyomas Treated with Leuprolide Acetate Compared with 126 Controls
  The American Journal of Surgical Pathology, 1996
• Leuprolide acetate treatment and myoma arterial size
  Obstetrics & Gynecology, 1995
• Morphological Changes in Uterine Leiomyomas Treated by GnRH Agonist Goserelin
  International Journal of Gynecological Pathology, 1995
• Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women
  Fertility and Sterility, 1992
• The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
• Treatment of uterine fibroids: Current findings withgonadotropin-releasing hormone agonists
  American Journal of Obstetrics and Gynecology, 1992
• Symptom-Free Interval After Triptorelin Treatment of Uterine Fibroids: Long-Term Results
  Gynecological Endocrinology, 1992
• Histopathological changes in leiomyomata treated with leuprolide acetate
  Fertility and Sterility, 1990
• Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesis
  American Journal of Obstetrics and Gynecology, 1990
• A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata
  Fertility and Sterility, 1989